This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Premaitha gives an update on Illumina's UK lawsuit

( April 20, 2016, 15:00 GMT | Official Statement) -- MLex Summary: Premaitha Health has provided an update on legal proceedings it faces in a London court in connection with two patent infringement lawsuits filed by Illumina. The trial has been rescheduled from October to the next available date, which is likely to be in summer 2017, the company said. Premaitha also said that it has also now presented its defence to the court, alleging that Illumina's claims were filed to extend its dominant position in the next generation sequencing market. The High Court gave Illumina until May 28 to present any arguments as to why Premaitha's application to include the antitrust defence shouldn't be accepted.Full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections